A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.
Dado Ruvic | Reuters
The Food and Drug Administration on Tuesday approved Novavax‘s updated Covid vaccine under emergency use, putting the shot on track to roll out weeks after new jabs from Pfizer and Moderna reached Americans.
Novavax’s new single-strain vaccine, which targets omicron subvariant XBB.1.5, still needs a recommendation from the Centers for Disease Control and Prevention before patients can access it at pharmacies, health centers and other distribution sites. The CDC could sign off as soon Tuesday.
But the company said last month that doses of the shot arrived in the U.S. and will be “ready for release” after the agency signs off.
Last month, the FDA and CDC greenlit XBB.1.5 shots from Pfizer and Moderna for all Americans ages six months and older. Those broad eligibility…
